345264-02-0

Basic information

• Product Name: (5,6-dihydro-4H-pyrrolo[3,2,1-ij]quinolin-1-yl)-oxo-acetic acid Methyl ester, (5,6-dihydro-4H-pyrrolo[3,2,1-ij]quinolin-1-yl)-oxoacetic acid Methyl ester
• Synonyms: (5,6-dihydro-4H-pyrrolo[3,2,1-ij]quinolin-1-yl)-oxo-acetic acid Methyl ester, (5,6-dihydro-4H-pyrrolo[3,2,1-ij]quinolin-1-yl)-oxoacetic acid Methyl ester;Methyl 2-(5,6-dihydro-4H-pyrrolo[3,2,1-ij]quinolin-1-yl)-2-oxoacetate;(5,6-dihydro-4H-pyrrolo[3,2,1-ij]quinolin-1-yl)-oxoacetic acid Methyl ester
• CAS NO: 345264-02-0
• Molecular Formula: C₁₄H₁₃NO₃
• Molecular Weight: 243.25792
• Mol File: 345264-02-0.mol
• Article Data: 9

Chemical Properties

• Appearance: /
• CAS DataBase Reference: (5,6-dihydro-4H-pyrrolo[3,2,1-ij]quinolin-1-yl)-oxo-acetic acid Methyl ester, (5,6-dihydro-4H-pyrrolo[3,2,1-ij]quinolin-1-yl)-oxoacetic acid Methyl ester(CAS DataBase Reference)
• NIST Chemistry Reference: (5,6-dihydro-4H-pyrrolo[3,2,1-ij]quinolin-1-yl)-oxo-acetic acid Methyl ester, (5,6-dihydro-4H-pyrrolo[3,2,1-ij]quinolin-1-yl)-oxoacetic acid Methyl ester(345264-02-0)
• EPA Substance Registry System: (5,6-dihydro-4H-pyrrolo[3,2,1-ij]quinolin-1-yl)-oxo-acetic acid Methyl ester, (5,6-dihydro-4H-pyrrolo[3,2,1-ij]quinolin-1-yl)-oxoacetic acid Methyl ester(345264-02-0)

Safety Data

• Hazardous Substances Data: 345264-02-0(Hazardous Substances Data)

Usage

General Description

"(5,6-dihydro-4H-pyrrolo[3,2,1-ij]quinolin-1-yl)-oxo-acetic acid Methyl ester and (5,6-dihydro-4H-pyrrolo[3,2,1-ij]quinolin-1-yl)-oxoacetic acid Methyl ester are both chemical compounds with similar molecular structures. They are both esters of the respective carboxylic acids, and contain a pyrroloquinoline core structure. These compounds may have potential applications in the pharmaceutical industry, particularly in drug development and medicinal chemistry. Further research and study may be needed to determine the specific properties and potential uses of these chemicals in various fields."

Upstream product

• 67-56-1 methanol 
• 5840-01-7 5,6-dihydro-4H-pyrrolo-[3,2,1-ij]quinoline 
• 124-41-4 sodium methylate 
• 79-37-8 oxalyl dichloride 
• 635-46-1 1,2,3,4-tetrahydroisoquinoline 
• 152712-44-2 3-(3,4-dihydro-2H-quinolin-1-yl)-2-oxopropionic acid ethyl ester 
• 124730-53-6 5,6-dihydro-4H-pyrrolo [3,2,1-ij]quinoline-1-carboxylic acid ethyl ester 
• 124730-56-9 5,6-dihydro-4H-pyrrolo[3,2,1-ij]quinoline-1-carboxylic acid 

Downstream Products

• 345261-20-3 3-(5,6-dihydro-4H-pyrrolo[3,2,1-ij]quinolin-1-yl)-4-(1H-indol-3-yl)-1H-pyrrole-2,5-dion 
• 905854-16-2 3-(5,6-dihydro-4H-pyrrolo[3,2,1-ij]quinolin-1-yl)-4-(2-chloro-4-fluorophenyl)pyrrole-2,5-dione 
• 905854-02-6 Tivantinib 
• 1000873-98-2 (±)-cis-3-(5,6-dihydro-4H-pyrrolo[3,2,1-ij]quinolin-1-yl)-4-(1H-indol-3-yl)pyrrolidine-2,5-dione 
• 1000873-98-2 (±)-trans-3-(5,6-dihydro-4H-pyrrolo[3,2,1-ij]quinolin-1-yl)-4-(1H-indol-3-yl)pyrrolidine-2,5-dione 
• 1313508-66-5 (3R,4R)-3-(5,6-dihydro-4H-pyrrolo[3,2,1-ij]quinolin-1-yl)-4-(1H-indol-3-yl)pyrrolidine-2,5-dione pseudoephedrine complex 
• 1000873-98-2 3(S),4(R)-3-(5,6-dihydro-4H-pyrrolo[3,2,1-ij]quinolin-1-yl)-4-(1H-indol-3-yl)pyrrolidine-2,5-dione 
• 1000873-98-2 tivatinib 
• 905854-03-7 (+)-3(S),4(S)-3-(5,6-dihydro-4H-pyrrolo[3,2,1-j]quinolin-1-yl)-4-(1H-indol-3-yl)pyrrolidine-2,5-dione 

Relevant articles and documents

COMBINATIONAL COMPOSITIONS AND METHODS FOR TREATMENT OF CANCER

The present invention provides methods of treating a cell proliferative disorder, such as a cancer, by administering to a subject in need thereof a therapeutically effective amount of a pyrroloquinolinyl-pyrrole-2,5-dione compound or a pyrroloquinolinyl-pyrrolidine-2,5-dione compound in combination with a therapeutically effective amount of a second anti-proliferative agent.

Pyrroloquinolinyl-Pyrrolidine-2,5-Dione Compositions And Methods For Preparing And Using Same

The present invention relates to pyrroloquinolinyl-pyrrolidine-2,5-dione compounds and methods of synthesizing these compounds. The present invention also relates to pharmaceutical compositions containing pyrroloquinolinyl-pyrrolidine-2,5-dione compounds

HDAC INHIBITORS

The present invention provides hydroxamic acid compounds, and methods of preparation of these compounds. The present invention also relates to pharmaceutical compositions comprising the hydroxamic acid compounds. The present invention provides methods of treating a cell proliferative disorder, such as a cancer, by administering to a subject in need thereof a therapeutically effective amount of a compound of the present invention.